. | Male patients (n = 104) . | Female patients without children (n = 42) . | Female patients with children (n = 37) . |
---|---|---|---|
Confirmation of MFS diagnosis before conceiving | n/a | n/a | 22% (n = 8) |
Aortic events | 71% (n = 74) | 69% (n = 29) | 84% (n = 31) |
Confirmation of MFS diagnosis before aortic event | 55% (n = 41) | 79% (n = 23) | 55% (n = 17) |
TAAD | 18% (n = 19) | 10% (n = 4) | 32% (n = 12) |
Confirmation of MFS diagnosis before TAAD | 5% (n = 1) | 25% (n = 1) | 42% (n = 5) |
TBAD | 16% (n = 17) | 10% (n = 4) | 27% (n = 10) |
Confirmation of MFS diagnosis before TBAD | 65% (n = 11) | 75% (n = 3) | 70% (n = 7) |
. | Male patients (n = 104) . | Female patients without children (n = 42) . | Female patients with children (n = 37) . |
---|---|---|---|
Confirmation of MFS diagnosis before conceiving | n/a | n/a | 22% (n = 8) |
Aortic events | 71% (n = 74) | 69% (n = 29) | 84% (n = 31) |
Confirmation of MFS diagnosis before aortic event | 55% (n = 41) | 79% (n = 23) | 55% (n = 17) |
TAAD | 18% (n = 19) | 10% (n = 4) | 32% (n = 12) |
Confirmation of MFS diagnosis before TAAD | 5% (n = 1) | 25% (n = 1) | 42% (n = 5) |
TBAD | 16% (n = 17) | 10% (n = 4) | 27% (n = 10) |
Confirmation of MFS diagnosis before TBAD | 65% (n = 11) | 75% (n = 3) | 70% (n = 7) |
Overview regarding confirmation of diagnosis and aortic events in male and female patients with or without children. All MFS patients with aortic events divided by sex and gender and subgroups.
MFS: Marfan syndrome; n/a: not available; TAAD: Stanford type A acute aortic dissection; TBAD: Stanford type B acute aortic dissection.
. | Male patients (n = 104) . | Female patients without children (n = 42) . | Female patients with children (n = 37) . |
---|---|---|---|
Confirmation of MFS diagnosis before conceiving | n/a | n/a | 22% (n = 8) |
Aortic events | 71% (n = 74) | 69% (n = 29) | 84% (n = 31) |
Confirmation of MFS diagnosis before aortic event | 55% (n = 41) | 79% (n = 23) | 55% (n = 17) |
TAAD | 18% (n = 19) | 10% (n = 4) | 32% (n = 12) |
Confirmation of MFS diagnosis before TAAD | 5% (n = 1) | 25% (n = 1) | 42% (n = 5) |
TBAD | 16% (n = 17) | 10% (n = 4) | 27% (n = 10) |
Confirmation of MFS diagnosis before TBAD | 65% (n = 11) | 75% (n = 3) | 70% (n = 7) |
. | Male patients (n = 104) . | Female patients without children (n = 42) . | Female patients with children (n = 37) . |
---|---|---|---|
Confirmation of MFS diagnosis before conceiving | n/a | n/a | 22% (n = 8) |
Aortic events | 71% (n = 74) | 69% (n = 29) | 84% (n = 31) |
Confirmation of MFS diagnosis before aortic event | 55% (n = 41) | 79% (n = 23) | 55% (n = 17) |
TAAD | 18% (n = 19) | 10% (n = 4) | 32% (n = 12) |
Confirmation of MFS diagnosis before TAAD | 5% (n = 1) | 25% (n = 1) | 42% (n = 5) |
TBAD | 16% (n = 17) | 10% (n = 4) | 27% (n = 10) |
Confirmation of MFS diagnosis before TBAD | 65% (n = 11) | 75% (n = 3) | 70% (n = 7) |
Overview regarding confirmation of diagnosis and aortic events in male and female patients with or without children. All MFS patients with aortic events divided by sex and gender and subgroups.
MFS: Marfan syndrome; n/a: not available; TAAD: Stanford type A acute aortic dissection; TBAD: Stanford type B acute aortic dissection.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.